Sleep Quality as a Predictor of Quality-of-Life and Emotional Status Impairment in Patients with Chronic Spontaneous Urticaria: A Cross-Sectional Study
Metadata
Show full item recordAuthor
Sánchez Díaz, Manuel; Rodríguez Pozo, Juan Ángel; Latorre Fuentes, Jose M.; Salazar Nievas, María Carmen; Molina Leyva, Alejandro; Arias Santiago, Salvador AntonioEditorial
MDPI
Materia
Urticaria Sleep quality Quality of life
Date
2023-02-16Referencia bibliográfica
Sánchez-Díaz, M.; Rodríguez-Pozo, J.Á.; Latorre-Fuentes, J.M.; Salazar-Nievas, M.C.; Alejandro, M.-L.; Arias-Santiago, S. Sleep Quality as a Predictor of Quality-of-Life and Emotional Status Impairment in Patients with Chronic Spontaneous Urticaria: A Cross-Sectional Study. Int. J. Environ. Res. Public Health 2023, 20, 3508. https://doi.org/10.3390/ijerph20043508
Abstract
Chronic Spontaneous Urticaria (CSU) leads to a decreased quality of life in patients because
of pruritus and skin lesions. However, there is still little evidence on the impact that a worse sleep
quality could have on the quality of life and emotional disorders in these patients. The aims of
the present study are to analyze the potential impact of sleep quality on the quality-of-life and
emotional status of patients with CSU. A cross-sectional study of 75 CSU patients was performed.
Socio-demographic variables and disease activity, quality of life, sleep, sexual disfunction, anxiety,
depression and personality traits were collected. A majority of 59 of the patients suffered from poor
sleep quality. Sleep quality impairment was associated with worse disease control, greater pruritus
and swelling and poorer general and urticaria-related quality-of-life (p < 0.05). Patients with poor
sleep quality showed an increased prevalence of anxiety (1.62-fold) and depression risk (3.93-fold).
Female sexual dysfunction, but not male, was found to be linked to poorer sleep quality (p = 0.04).
To conclude, sleep quality impairment in patients with CSU is related to poor quality-of-life, worse
disease control and higher rates of anxiety and depression. Global management of the disease should
take sleep quality into account to improve the care of CSU patients.